4th Quarter - Report

ALBERTINE ENTERPRISES, INC. for BIOCORRX

Period 4th Quarter 2022 Filed Jan 12, 2023 Signed by James J Albertine

Official filing
Firm
ALBERTINE ENTERPRISES, INC.
Client
BIOCORRX
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Products and techniques that deal with drug and alcohol rehabilitation Appropriations

LobbyistCovered position, as disclosed
JAMES ALBERTINE —
JOHN ALBERTINE —

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.